Very little progress has been made in the treatment of patients with metastatic squamous cell lung cancer over the past 2 decades. Identification of novel molecular alterations for targeted therapies is necessary to improve outcomes. Advances in genomic technology have now made it possible to analyze the genomic landscape of tumor tissues comprehensively. We summarize here key findings from the comprehensive analysis of squamous cell lung cancer by The Cancer Genome Atlas group and discuss the clinical implications of these findings.

Original languageEnglish
JournalONCOLOGY (United States)
Issue number9
StatePublished - 2013


Dive into the research topics of 'Clinical applications of the cancer genome atlas project (TCGA) for squamous cell lung Carcinoma'. Together they form a unique fingerprint.

Cite this